C-Kit (CD117) expression in classic Kaposi's sarcoma: Experimental dermatology

Clinical and Experimental Dermatology

Volumn 35, Issue 5, 2010, Pages 525-530

  Kandemir, N O ^a   Gun, B D ^a   Bahadir, B ^a   Yurdakan, G ^a   Ozdemir, N ^b   Karadayi, N ^b   Ozdamar, S O ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^b Dr Lutfi Kirdar Kartal Research and Training Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; LATENCY ASSOCIATED NUCLEAR ANTIGEN 1; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KAPOSI SARCOMA; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS C-KIT; SARCOMA, KAPOSI; SKIN NEOPLASMS;

EID: 77953336840     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03661.x     Document Type: Article

References (25)

1. Weiss SW, Goldblum JR. Enzinger and Weiss's Soft Tissue Tumors, 4th edn. St Louis
2. Iscovich J, Boffetta P, Franceschi S et al. Classic Kaposi sarcoma. Epidemiol Risk Factors Cancer 2000 88 : 500 517.
3. Ensoli B, Sgadari C, Barillari G et al. Biology of Kaposi's sarcoma. Eur J Cancer 2001 37 : 1251 1269.
4. Schwartz RA. Kaposi's sarcoma: an update. J Surg Oncol 2004 87 : 146 151.
5. Robin YM, Guillou L, Michels JJ et al. Human herpesvirus 8 immunostaining: a sensitive and specific method for diagnosing Kaposi sarcoma in paraffin embedded sections. Am J Clin Pathol 2004 121 : 330 334.
6. Viejo-Borbolla A, Schulz TF. Kaposi's sarcoma associated herpesvirus: key aspects of epidemiology and pathogenesis. AIDS Rev 2003 5 : 222 229.
7. Bubman D, Cesarman E. Pathogenesis of Kaposi's sarcoma. Hematol Oncol Clin North Am 2003 17 : 717 745.
8. Bryan BA, Dyson OF, McCubrey JA et al. Biology of Kaposi's sarcoma-associated herpesvirus. Front Biosci 2005 10 : 2882 2891.
9. Hengge UR, Ruzicka T, Tyring SK et al. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis 2002 2 : 281 292.
10. Raggo C, Ruhl R, Shane M et al. Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus. Cancer Res 2005 65 : 5084 5095.
11. Poole LJ, Yu Y, Kim PS et al. Altered patterns of cellular gene expression in dermal microvascular endothelial cells infected with Kaposi's sarcoma-associated herpesvirus. J Virol 2002 76 : 3395 3420.
12. Moses AV, Jarvis MA, Raggo C et al. Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells. J Virol 2002 76 : 8383 8399.
13. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A et al. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 1998 11 : 728 734.
14. Miettinen M, Sarlomo-Rikala M, Lasota J. Kit expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of c-kit. Mod Pathol 2000 13 : 536 541.
15. Pantanowitz L, Schwartz E, Dezube BJ et al. c-Kit expression in AIDS-related, classic, and African endemic Kaposi sarcoma. Appl Immunohistochem Molecul Morph 2005 13 : 162 166.
16. Pantanowitz L, Dezube BJ, Pinkus GS et al. Histological characterization of regression in acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Cutan Pathol 2004 31 : 26 34.
17. Koon HB, Bubley GJ, Pantanowitz L et al. Imatinib-induced regression of AIDS-related Kaposi's sarcoma. J Clin Oncol 2005 22 : 982 983.
18. Dezube BJ. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment. Expert Rev Anticancer Ther 2002 2 : 193 200.
19. Moses AV, Jarvis MA, Raggo C et al. A functional genomics approach to Kaposi's sarcoma. Ann N Y Acad Sci 2002 975 : 180 191.
20. Dittmer DP, Krown SE. Targeted therapy for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus. Curr Opin Oncol 2007 19 : 452 457.
21. McAllister SC, Früh K, Moses AV. Functional genomics and the development of pathogenesis-targeted therapies for Kaposi's sarcoma. Pharmacogenomics 2005 6 : 235 244.
22. Di Lorenzo G, Konstantinopoulos PA, Pantanowitz L et al. Management of AIDS-related Kaposi's sarcoma. Lancet Oncol 2007 8 : 167 176.
23. Cattelan AM, Trevenzoli M, Aversa SM. Recent advances in the treatment of AIDS-related Kaposi's sarcoma. Am J Clin Dermatol 2002 3 : 451 462.
24. Cattelan AM, Trevenzoli M, Aversa SM. Novel pharmacological therapies for the treatment of AIDS-related Kaposi's sarcoma. Expert Opin Invest Drugs 2004 13 : 501 513.
25. Dezube BJ, Pantanowitz L, Aboulafia DM. Management of AIDS-related Kaposi sarcoma: advances in target discovery and treatment. AIDS Read 2004 14 : 236 243.